Clinical Trials Browser

Phase 2 × Withdrawn × Gadolinium DTPA × Clear all

NCT00373152 2017-12-05

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms